Early aggressive treatment of rheumatoid arthritis is associated with improved disease control, slower radiological progression and improved functional outcomes. Tumor necrosis factor blocking therapy ...
Parallel Learning raised a $20M Series B funding round. The round was led by Valspring Capital, with additional capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback